BIO KEY INTERNATIONAL INC (BKYI)
Data as of , from SEC Form 4 filings.
See up to 3 months of BKYI. The 7-day demo opens the 1M and 3M ranges and puts BKYI on your watchlist.
Start 7-day demoData as of , from SEC Form 4 filings.
See up to 3 months of BKYI. The 7-day demo opens the 1M and 3M ranges and puts BKYI on your watchlist.
Start 7-day demo
Michael W. Depasquale - Officer
James David Sullivan - OfficerMichael W. Depasquale - OfficerMichael W. Depasquale - OfficerJames David Sullivan - OfficerMichael W. Depasquale - OfficerBIO-key International Inc is a identity and access management (IAM) platform provider enabling secure work-from-anywhere for enterprise, education, and government customers using secure multi-factor authentication (MFA). Its products include PortalGuard and PortalGuard Identity-as-a-Service (IDaaS) enterprise IAM, WEB-key biometric civil and large-scale ID infrastructure, MobileAuth mobile phone authentication application for iOS and Android, and high-quality, low-cost accessory fingerprint scanner and FIDO-compliant hardware to provide a full and complete solution for identity-innovating customers. The company operates as one operating segment. Its solutions are Passwordless Authentication, Secure Roving Employees, Education, Financial Services, Government, Healthcare, Manufacturing, etc.
No Form 4 activity for BKYI in the last 90 days.
24 Form 4 filings on record, the earliest from Nov 8, 2024, newest first.
| Traded | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| James David Sullivan - Officer | Grant or award | Common Stock | 250 | $3.83 | $958 | |
| Michael W. Depasquale - Officer | Grant or award | Common Stock | 250 | $3.83 | $958 | |
| Mira K. Lacous - Officer | Grant or award | Common Stock | 250 | $3.83 | $958 | |
| Michael W. Depasquale - Officer | Open-market purchase | Common Stock | 2,500 | $7.50 | $2K | |
| Michael W. Depasquale - Officer | Open-market purchase | Common Stock | 1,617 | $8.40 | $1K | |
 Cecilia C. Welch - Officer | Grant or award | Common Stock | 35,000 | $0.00 | - | |
| James David Sullivan - Officer | Grant or award | Common Stock | 40,000 | $0.00 | - | |
| Mira K. Lacous - Officer | Grant or award | Common Stock | 25,000 | $0.00 | - | |
| Michael W. Depasquale - Officer | Grant or award | Common Stock | 45,000 | $0.00 | - | |
| James David Sullivan - Officer | Open-market purchase | Common Stock | 10,000 | $7.70 | $8K | |
| Michael W. Depasquale - Officer | Grant or award | Common Stock | 139 | $7.00 | $97 | |
| James David Sullivan - Officer | Grant or award | Common Stock | 139 | $7.00 | $97 | |
| Mira K. Lacous - Officer | Grant or award | Common Stock | 139 | $7.00 | $97 | |
| Michael W. Depasquale - Officer | Open-market purchase | Common Stock | 5,000 | $7.80 | $4K | |
| Michael W. Depasquale - Officer | Open-market purchase | Common Stock | 5,000 | $8.10 | $4K | |
| Fong Wong Kwok - Officer | Grant or award | Common Stock | 2,000 | $0.00 | - | |
| Emmanuel Alia - Director | Grant or award | Common Stock | 5,000 | $0.00 | - | |
| Robert J. Michel - Director | Grant or award | Common Stock | 5,000 | $0.00 | - | |
| Robert J. Michel - Director | Grant or award | Common Stock | 1,266 | $7.90 | $1K | |
| Cameron E. Williams - Director | Grant or award | Common Stock | 5,000 | $0.00 | - | |
| Cameron E. Williams - Director | Grant or award | Common Stock | 1,266 | $0.00 | - | |
| Cameron E. Williams - Director | Grant or award | Common Stock | 3,897 | $0.00 | - | |
| Emmanuel Alia - Director | Grant or award | Common Stock | 3,897 | $0.00 | - | |
| Robert J. Michel - Director | Grant or award | Common Stock | 3,897 | $0.00 | - | |
| Robert J. Michel - Director | Grant or award | Common Stock | 2,587 | $0.00 | - | |
| Emmanuel Alia - Director | Grant or award | Common Stock | 2,587 | $0.00 | - | |
| Cameron E. Williams - Director | Grant or award | Common Stock | 2,587 | $0.00 | - |
BIO KEY INTERNATIONAL INC (BKYI) has filed no insider reports in the last 90 days. The most recent on record is dated 2 July 2026. The full record for BKYI runs to 24 Form 4 filings, the earliest from 8 November 2024. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
No insider purchases of BKYI were filed in the last 90 days. 5 purchases are on record for this company.
No insider sales of BKYI were filed in the last 90 days.
This page collects BKYI Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
